Stocks · Health care · Services-Medical Laboratories

Quest Diagnostics

DGX Clue Score42
United States Fiscal year ends December CIK 0001022079 Results filed 22 Oct 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
2,907
$251.24
$730.35K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
2,877
$250.49
$720.65K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
3,004
$249.40
$749.21K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
2,358
$248.38
$585.69K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
1,151
$246.98
$284.28K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
5,990
$246.26
$1.48M
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
3,818
$245.45
$937.14K
Michael E Prevoznik
28 Aug 2026
SVP & General Counsel
Sold after exercise
430
$244.51
$105.14K
Michael E Prevoznik
28 Aug 2026
SVP & General Counsel
Sold after exercise
6,237
$243.63
$1.52M
Michael E Prevoznik
28 Aug 2026
SVP & General Counsel
Sold after exercise
16,010
$242.88
$3.89M
Karthik Kuppusamy
4 Jun 2026
SVP, Clinical Solutions
Sold after exercise
8,147
$200.00
$1.63M
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
351
$209.10
$73.39K
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
1,619
$208.21
$337.09K
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
3,500
$207.08
$724.79K
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
10,122
$206.37
$2.09M
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
10,573
$205.21
$2.17M
Patrick Plewman
10 Feb 2026
SVP for Diagnostic Services
Sold after exercise
5,662
$204.00
$1.16M
J. E. Davis
25 Nov 2025
CEO and President
Sold after exercise
4,747
$192.97
$916.04K
J. E. Davis
25 Nov 2025
CEO and President
Sold after exercise
41,004
$192.27
$7.88M
J. E. Davis
25 Nov 2025
CEO and President
Sold after exercise
9,342
$191.59
$1.79M
Mark E Delaney
18 Nov 2025
SVP & Chief Commercial Officer
Sold after exercise
7,946
$187.35
$1.49M
Michael E Prevoznik
26 Sep 2025
SVP & General Counsel
Sold after exercise
144
$188.66
$27.17K
Michael E Prevoznik
26 Sep 2025
SVP & General Counsel
Sold after exercise
83
$187.22
$15.54K
Michael E Prevoznik
24 Sep 2025
SVP & General Counsel
Sold after exercise
175
$187.02
$32.73K
Michael E Prevoznik
23 Sep 2025
SVP & General Counsel
Sold after exercise
28,288
$187.12
$5.29M
Patrick Plewman
19 Aug 2025
SVP for Diagnostic Services
Sold after exercise
4,532
$183.00
$829.36K
Patrick Plewman
6 Aug 2025
SVP for Diagnostic Services
Sold after exercise
1,975
$175.00
$345.63K
Patrick Plewman
6 Aug 2025
SVP for Diagnostic Services
Sold after exercise
3,560
$175.00
$623.00K
Karthik Kuppusamy
30 Jul 2025
SVP, Clinical Solutions
Sold after exercise
5,224
$167.40
$874.50K
Karthik Kuppusamy
30 Jul 2025
SVP, Clinical Solutions
Sold after exercise
3,045
$167.40
$509.73K
Michael E Prevoznik
29 Nov 2024
SVP & General Counsel
Sold after exercise
32,137
$163.15
$5.24M
Michael E Prevoznik
29 Nov 2024
SVP & General Counsel
Sold after exercise
3,009
$162.26
$488.24K
Catherine T. Doherty
27 Nov 2024
EVP, Regional Businesses
Sold after exercise
28,300
$163.13
$4.62M
Catherine T. Doherty
27 Nov 2024
EVP, Regional Businesses
Sold after exercise
4,803
$162.14
$778.78K
Michael J Deppe
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
5,189
$154.74
$802.96K
Michael J Deppe
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
2,331
$154.03
$359.05K
Michael J Deppe
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
2,600
$152.71
$397.05K
Michael J Deppe
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
4,135
$154.74
$639.83K
Michael J Deppe
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
2,400
$153.98
$369.56K
Michael J Deppe
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
2,100
$152.70
$320.68K
Michael E Prevoznik
29 Aug 2024
SVP & General Counsel
Sold after exercise
32,551
$154.97
$5.04M
Timothy M Ring
1 Dec 2022
Director
Sold after exercise
2,025
$152.50
$308.81K
Catherine T. Doherty
28 Nov 2022
SVP, Regional Businesses
Sold after exercise
23,407
$149.37
$3.50M
Catherine T. Doherty
28 Nov 2022
SVP, Regional Businesses
Sold after exercise
17,358
$148.92
$2.58M
Timothy M Ring
1 Nov 2022
Director
Sold after exercise
2,000
$144.06
$288.12K
Michael J Deppe
26 Oct 2022
VP, Corp. Controller & CAO
Sold after exercise
15,497
$145.00
$2.25M
Timothy M Ring
3 Oct 2022
Director
Sold after exercise
2,000
$123.39
$246.78K
Timothy M Ring
1 Sep 2022
Director
Sold after exercise
2,000
$125.02
$250.04K
Timothy M Ring
1 Aug 2022
Director
Sold after exercise
2,000
$136.04
$272.08K
Timothy M Ring
1 Jul 2022
Director
Sold after exercise
2,000
$133.47
$266.94K
Stephen H Rusckowski
25 May 2022
Chairman, CEO and President
Sold after exercise
900
$142.13
$127.92K
Stephen H Rusckowski
25 May 2022
Chairman, CEO and President
Sold after exercise
4,131
$141.35
$583.91K
Stephen H Rusckowski
25 May 2022
Chairman, CEO and President
Sold after exercise
9,823
$140.58
$1.38M
Stephen H Rusckowski
25 May 2022
Chairman, CEO and President
Sold after exercise
651
$142.15
$92.54K
Stephen H Rusckowski
25 May 2022
Chairman, CEO and President
Sold after exercise
2,565
$141.36
$362.59K
Stephen H Rusckowski
25 May 2022
Chairman, CEO and President
Sold after exercise
6,821
$140.60
$959.05K
Stephen H Rusckowski
24 May 2022
Chairman, CEO and President
Sold after exercise
156,282
$140.12
$21.90M
Stephen H Rusckowski
24 May 2022
Chairman, CEO and President
Sold after exercise
126,126
$140.12
$17.67M
Stephen H Rusckowski
23 May 2022
Chairman, CEO and President
Sold after exercise
300
$142.24
$42.67K
Stephen H Rusckowski
23 May 2022
Chairman, CEO and President
Sold after exercise
1,000
$141.51
$141.51K
Stephen H Rusckowski
23 May 2022
Chairman, CEO and President
Sold after exercise
41,268
$140.12
$5.78M
Stephen H Rusckowski
23 May 2022
Chairman, CEO and President
Sold after exercise
200
$142.26
$28.45K
Stephen H Rusckowski
23 May 2022
Chairman, CEO and President
Sold after exercise
800
$141.54
$113.23K
Stephen H Rusckowski
23 May 2022
Chairman, CEO and President
Sold after exercise
33,898
$140.12
$4.75M
Michael E Prevoznik
17 May 2022
SVP & General Counsel
Sold after exercise
50,604
$139.97
$7.08M
Catherine T. Doherty
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
14,575
$157.53
$2.30M
Catherine T. Doherty
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
15,908
$156.86
$2.50M
Catherine T. Doherty
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
3,532
$155.77
$550.19K
Catherine T. Doherty
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
3,250
$154.79
$503.07K
Catherine T. Doherty
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
300
$153.38
$46.01K
Stephen H Rusckowski
29 Jul 2021
Chairman, CEO and President
Sold after exercise
4,193
$141.22
$592.12K
Stephen H Rusckowski
29 Jul 2021
Chairman, CEO and President
Sold after exercise
5,300
$140.59
$745.13K
Stephen H Rusckowski
28 Jul 2021
Chairman, CEO and President
Sold after exercise
139,751
$140.14
$19.58M
Gail R Wilensky
27 Jul 2021
Director
Sold after exercise
6,111
$139.27
$851.07K
Gail R Wilensky
27 Jul 2021
Director
Sold after exercise
6,111
$139.32
$851.40K
Stephen H Rusckowski
27 Jul 2021
Chairman, CEO and President
Sold after exercise
32,788
$140.01
$4.59M
Stephen H Rusckowski
26 Jul 2021
Chairman, CEO and President
Sold after exercise
5,813
$140.03
$813.99K
Michael E Prevoznik
5 May 2021
SVP & General Counsel
Sold after exercise
44,939
$137.00
$6.16M
Mark Guinan
24 Dec 2020
Executive Vice President & CFO
Sold after exercise
22,563
$121.18
$2.73M
Mark Guinan
24 Dec 2020
Executive Vice President & CFO
Sold after exercise
59,193
$120.06
$7.11M
Gail R Wilensky
24 Nov 2020
Director
Sold after exercise
6,111
$126.02
$770.12K
Michael J Deppe
21 Oct 2020
VP, Corp. Controller & CAO
Sold after exercise
4,750
$125.00
$593.75K
Michael J Deppe
21 Oct 2020
VP, Corp. Controller & CAO
Sold after exercise
5,700
$125.00
$712.50K
Stephen H Rusckowski
16 Oct 2020
Chairman, CEO and President
Sold after exercise
291,997
$120.00
$35.04M
Michael E Prevoznik
14 Oct 2020
SVP & General Counsel
Sold after exercise
35,591
$119.00
$4.24M
Catherine T. Doherty
2 Sep 2020
SVP, Group Exec. Clin. Fran.
Sold after exercise
3,776
$111.13
$419.62K
Catherine T. Doherty
2 Sep 2020
SVP, Group Exec. Clin. Fran.
Sold after exercise
54,616
$110.57
$6.04M
Timothy M Ring
8 Jun 2020
Director
Sold after exercise
11,730
$116.60
$1.37M
Mark Guinan
8 Jun 2020
Executive Vice President & CFO
Sold after exercise
8,524
$118.60
$1.01M
Mark Guinan
8 Jun 2020
Executive Vice President & CFO
Sold after exercise
18,246
$117.65
$2.15M
Mark Guinan
8 Jun 2020
Executive Vice President & CFO
Sold after exercise
45,826
$116.81
$5.35M
Stephen H Rusckowski
27 Apr 2020
Chairman, CEO and President
Sold after exercise
11,717
$112.01
$1.31M
Stephen H Rusckowski
10 Mar 2020
Chairman, CEO and President
Sold after exercise
100
$112.19
$11.22K
Stephen H Rusckowski
6 Mar 2020
Chairman, CEO and President
Sold after exercise
2,000
$116.27
$232.54K
Stephen H Rusckowski
6 Mar 2020
Chairman, CEO and President
Sold after exercise
3,937
$115.45
$454.53K
Stephen H Rusckowski
6 Mar 2020
Chairman, CEO and President
Sold after exercise
16,426
$114.24
$1.88M
Stephen H Rusckowski
6 Mar 2020
Chairman, CEO and President
Sold after exercise
36,790
$113.65
$4.18M
Stephen H Rusckowski
6 Mar 2020
Chairman, CEO and President
Sold after exercise
171,025
$112.21
$19.19M
J. E. Davis
2 Jan 2020
EVP, General Diagnostics
Sold after exercise
8,853
$106.51
$942.94K
J. E. Davis
2 Jan 2020
EVP, General Diagnostics
Sold after exercise
69,003
$105.45
$7.28M
J. E. Davis
2 Jan 2020
EVP, General Diagnostics
Sold after exercise
7,423
$106.51
$790.65K
J. E. Davis
2 Jan 2020
EVP, General Diagnostics
Sold after exercise
58,258
$105.46
$6.14M
Michael E Prevoznik
27 Nov 2019
SVP & General Counsel
Sold after exercise
500
$107.83
$53.92K
Michael E Prevoznik
27 Nov 2019
SVP & General Counsel
Sold after exercise
32,193
$107.53
$3.46M
Michael E Prevoznik
27 Nov 2019
SVP & General Counsel
Sold after exercise
11,863
$107.15
$1.27M
Gail R Wilensky
26 Nov 2019
Director
Sold after exercise
8,000
$107.17
$857.35K
Michael J Deppe
17 Sep 2019
VP, Corp. Controller & CAO
Sold after exercise
5,000
$106.00
$530.00K
Mark Guinan
13 Jun 2019
Executive Vice President & CFO
Sold after exercise
73,005
$100.00
$7.30M
Stephen H Rusckowski
13 Jun 2019
Chairman, President and CEO
Sold after exercise
244,565
$100.00
$24.46M
J. E. Davis
24 Apr 2019
EVP, General Diagnostics
Sold after exercise
47,574
$95.00
$4.52M
Catherine T. Doherty
4 Apr 2019
SVP, Group Exec. Clin. Fran.
Sold after exercise
5,890
$90.59
$533.59K
Catherine T. Doherty
4 Apr 2019
SVP, Group Exec. Clin. Fran.
Sold after exercise
60,492
$90.59
$5.48M
Gail R Wilensky
22 Feb 2019
Director
Sold after exercise
8,000
$87.78
$702.22K
Everett Cunningham
10 Jul 2018
SVP, Commercial
Sold after exercise
40,328
$112.00
$4.52M
Michael E Prevoznik
10 Jul 2018
SVP & General Counsel
Sold after exercise
30,780
$113.07
$3.48M
Everett Cunningham
2 Jul 2018
SVP, Commercial
Sold after exercise
781
$110.12
$86.01K
Everett Cunningham
2 Jul 2018
SVP, Commercial
Sold after exercise
7,066
$109.63
$774.62K
Everett Cunningham
2 Jul 2018
SVP, Commercial
Sold after exercise
5,583
$110.07
$614.50K
Everett Cunningham
2 Jul 2018
SVP, Commercial
Sold after exercise
33,345
$109.60
$3.65M
Everett Cunningham
2 Jul 2018
SVP, Commercial
Sold after exercise
1,496
$110.12
$164.74K
Everett Cunningham
2 Jul 2018
SVP, Commercial
Sold after exercise
19,798
$109.64
$2.17M
Mark Guinan
25 May 2018
Executive Vice President & CFO
Sold after exercise
24,960
$106.14
$2.65M
Mark Guinan
25 May 2018
Executive Vice President & CFO
Sold after exercise
36,573
$105.42
$3.86M
Stephen H Rusckowski
25 May 2018
Chairman, President and CEO
Sold after exercise
168,490
$107.00
$18.03M
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
7,773
$104.77
$814.38K
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
2,800
$104.77
$293.36K
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
34,168
$104.09
$3.56M
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
1,300
$104.77
$136.20K
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
18,164
$104.09
$1.89M
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
1,427
$104.76
$149.49K
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
18,037
$104.09
$1.88M
Showing 250 of 295 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 656
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 50
Sales straight out of an exercise 166
Sales at will 79
Transactions with no price 0
Shares from compensation/vesting 5,989,127
Sales filed before the plan box existed 69
History held since 3 Oct 2006